Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2026-02-23 @ 1:53 PM
Study NCT ID:
NCT03046251
Status:
COMPLETED
Last Update Posted:
2025-01-24
First Post:
2017-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Natalizumab in Preventing Post-partum Relapses in Multiple Sclerosis
Sponsor:
State University of New York at Buffalo
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
US-TYS-14-10720
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None